How sertraline alleviates depressive syndrome by modulating the intrinsic connectivity networks (ICNs) remains elusive. Herein, we take a network-based investigation on SN to rationalize the functional and behavior effect of the sertraline treatment using resting-state functional connectivity (rsFC). Our study demonstrated that the sertraline treatment exhibited beneficial modulations on the DNMTL–SN–thalamus pathway for alleviating depressive syndromes in MDD patients.
This abstract and the presentation materials are available to members only; a login is required.